Patents by Inventor Claudia Krapp

Claudia Krapp has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • STABLE PROTEASE VARIANTS
    Publication number: 20230092791
    Abstract: The present invention relates to a protease variant which is at least 90% identical to the full length amino acid sequence of a Kumamolisin AS backbone as set forth in any of SEQ ID NOs 1-3, while maintaining proteolytic activity, or a fragment, fraction or shuffled variant thereof maintaining proteolytic activity, which protease variant demonstrates altered or improved stability compared to the Kumamolisin AS wildtype as set forth in SEQ ID NO 4, or the Kumamolisin AS backbone as set forth in any of SEQ ID NOs 1-3.
    Type: Application
    Filed: June 27, 2022
    Publication date: March 23, 2023
    Inventors: Andreas Michels, Andreas Scheidig, Christian Elend, Claudia Krapp, Thomas Horn
  • Stable protease variants
    Patent number: 11396648
    Abstract: The present invention relates to a protease variant which is at least 90% identical to the full length amino acid sequence of a Kumamolisin AS backbone as set forth in any of SEQ ID NOs 1-3, while maintaining proteolytic activity, or a fragment, fraction or shuffled variant thereof maintaining proteolytic activity, which protease variant demonstrates altered or improved stability compared to the Kumamolisin AS wildtype as set forth in SEQ ID NO 4, or the Kumamolisin AS backbone as set forth in any of SEQ ID NOs 1-3.
    Type: Grant
    Filed: December 22, 2017
    Date of Patent: July 26, 2022
    Assignee: EW NUTRITION GMBH
    Inventors: Andreas Michels, Andreas Scheidig, Christian Elend, Claudia Krapp, Thomas Horn
  • STABLE PROTEASE VARIANTS
    Publication number: 20190322994
    Abstract: The present invention relates to a protease variant which is at least 90% identical to the full length amino acid sequence of a Kumamolisin AS backbone as set forth in any of SEQ ID NOs 1-3, while maintaining proteolytic activity, or a fragment, fraction or shuffled variant thereof maintaining proteolytic activity, which protease variant demonstrates altered or improved stability compared to the Kumamolisin AS wildtype as set forth in SEQ ID NO 4, or the Kumamolisin AS backbone as set forth in any of SEQ ID NOs 1-3.
    Type: Application
    Filed: December 22, 2017
    Publication date: October 24, 2019
    Inventors: Andreas Michels, Andreas Scheidig, Christian Elend, Claudia Krapp, Thomas Horn